ctrl K

Watchlist Price Alert

Hikma Pharmaceuticals (HKMPF)

PNK: HKMPF · Real-Time Price · USD

26.20

-0.36 (-1.36%)

At close: May 01, 2025, 8:00 PM

Hikma Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	3.13B	2.88B	2.52B	2.55B	2.34B	2.21B	2.07B	1.94B	1.95B
Cost of Revenue	1.71B	1.47B	1.25B	1.25B	1.13B	1.11B	1.07B	1.02B	1B
Gross Profit	1.42B	1.41B	1.26B	1.3B	1.21B	1.1B	1B	915M	950M
Operating Income	612M	367M	591M	634M	540M	486M	428M	336M	401M
Interest Income	7.83M	7M	56M	42M	34M	30M	38M	49M	46M
Pretax Income	455M	281M	233M	544M	558M	491M	293M	-738M	210M
Net Income	359M	190M	188M	421M	431M	486M	282M	-843M	155M
Selling & General & Admin	568M	632M	509M	488M	506M	487M	467M	474M	429M
Research & Development	141M	149M	144M	143M	137M	150M	147M	121M	150M
Other Expenses	94M	259M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	803M	1.04B	976M	715M	621M	578M	673M	1.6B	694M
Interest Expense	75M	90M	77M	56M	56M	67M	80M	60M	104M
Selling & Marketing Expenses	n/a	-6M	n/a	n/a	42M	494M	224M	236M	221M
Cost & Expenses	2.52B	2.51B	2.23B	1.97B	1.75B	1.69B	1.74B	2.63B	1.69B
Income Tax Expense	93M	89M	42M	124M	128M	4M	8M	101M	52M
Shares Outstanding (Basic)	221.33M	223.53M	223.73M	231M	236M	242M	241M	240M	233M
Shares Outstanding (Diluted)	223.49M	222.37M	225M	233M	238M	243M	242M	240M	234M
EPS (Basic)	1.61	0.85	0.84	1.82	1.83	2.01	1.17	-3.51	0.67
EPS (Diluted)	1.61	0.85	0.84	1.81	1.81	2.00	1.17	-3.51	0.66
EBITDA	787M	791M	485M	744M	654M	584M	527M	554M	506M
EBIT	608M	619M	292M	600M	540M	486M	428M	-687M	401M
Depreciation & Amortization	179M	172M	193M	144M	91M	99M	121M	1.24B	146M